Kostenloser Versand ab €200

PEG MGF

2mg

❄️Lyophilized powder

€70.00€49.00Sparen €21.00 (30% Rabatt)
1

Rabatt pro Menge

MengeRabattPreis pro Einheit
5 - 1010%€44.10
11 - 2015%€41.65
21+20%€39.20

Strenge Tests durch unabhängige Labore

Jede Charge unserer Forschungschemikalien und Peptide wird von einem unabhängigen Labor auf Reinheit und Identität geprüft.

Gesamt: €49.00

Kaufen Sie & sammeln Sie 49 Punkte!

For laboratory research use only by qualified professionals. Not for human or veterinary use. Not for ingestion, injection, topical application, diagnostic, therapeutic, prophylactic or cosmetic use.

PEG MGF (identity unresolved) is supplied as a catalogued research material in 2 mg. It is intended only for controlled analytical, biochemical and non-clinical laboratory workflows. The catalogue amount identifies the nominal vial presentation; it is not a dose or a use instruction.

Identity hold: PEG MGF is not a standardized molecular name. “MGF” may refer to an IGF1 Ec-domain-derived peptide, vendor sequence variants or other constructs, while PEGylation creates additional molecular distributions. Do not assign a sequence, formula, mass, CAS number or CID until peptide and conjugate specifications are documented and batch-confirmed.

Product identity

Identity must be assigned to the exact batch rather than to a marketed name alone. Sequence, terminal modifications, conjugation, salt or counter-ion, hydration state and excipients may change the applicable mass and registry identifiers. The batch CoA and SDS take precedence over literature identifiers shown below.

Chemical properties and registry information

PropertyValue
Name and synonymsPEG MGF; PEGylated mechano growth factor — non-standard catalogue name
Material categoryUnresolved PEG-peptide conjugate marketed as PEG MGF; not one standardized molecular entity
Sequence or structural definitionNot assigned: the peptide sequence, termini and stereochemistry are not confirmed
Molecular formulaNo single molecular formula: peptide identity, PEG composition and conjugation stoichiometry are unresolved
Average molecular massNo single molecular mass: PEG is polydisperse and its nominal mass, distribution and loading are unspecified; 2 mg is only a catalogue presentation
CAS Registry NumberNot assigned: no exact conjugate identity has been established
PubChem CIDNo exact-form PubChem CID assigned; do not substitute an unPEGylated peptide or IGF-1 record
Structural featuresUnresolved. Required attributes include exact peptide sequence and termini, PEG chemistry, nominal PEG mass and distribution, linear or branched architecture, conjugation site and linkage, substitution stoichiometry, free-peptide fraction and counter-ions
Physical formCatalogue vial; the exact physical state, salt or counter-ion and excipients are batch-specific and must be verified in the CoA and SDS.
Catalogue presentations2 mg
Batch identity and quality documentationLot-specific identity and available analytical reports must be verified against the CoA entry associated with the exact product size and batch.
Intended useAnalytical, biochemical and non-clinical laboratory research only; all human and veterinary uses are excluded.

Where an identifier is qualified or omitted, no unambiguous exact-form public assignment has been confirmed. Do not transfer an identifier from a related analogue, salt, conjugate or formulation.

Research context and evidence status

What the literature supports

IGF1 Ec-domain-derived peptides and various synthetic or PEGylated constructs have been examined in preclinical models, but “PEG MGF” is not a uniform literature material. PEG architecture and conjugation chemistry can alter every analytical and experimental comparison.

Evidence limitations

Published findings are construct-specific and include inconsistent results and analytical ambiguity around MGF-related species. Data for an unPEGylated peptide, another PEG conjugate or full-length IGF1Ec cannot authenticate this catalogue material or be transferred without direct structural comparability.

Do not release this description as a completed product specification while peptide and conjugate identity remain unresolved. Legal, advertising, customs, platform and payment-provider review must use the corrected exact-form specification, component and conjugation records, and batch analytical evidence; RUO wording does not resolve an ambiguous product identity.

ImportantResearch-use labeling does not itself determine the substance-specific legal status. The purchaser is responsible for confirming institutional authorization, local restrictions and lawful procurement, possession, import, export, storage and disposal.

Technical comparison

The comparison below is limited to structural and analytical distinctions. It does not compare clinical performance or recommend a use.

AspectThis catalogue materialComparator
IdentityUnresolved PEG-peptide conjugate sold under the PEG MGF nameUnPEGylated IGF1 Ec-domain-derived peptide or full-length IGF1Ec: chemically distinct materials
Structural distinctionIdentity depends on peptide sequence plus PEG mass distribution, architecture, linkage, site and stoichiometryAn unPEGylated peptide lacks the polymer distribution and conjugation-site heterogeneity
Analytical implicationRequire peptide mapping, conjugation-site evidence, PEG mass-distribution profiling, substitution stoichiometry, purity, free-peptide fraction and aggregate analysisNominal vial mass or detection of an MGF-related peptide cannot define the intact PEG conjugate
What is not impliedNo conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability.No conclusion about human or veterinary safety, efficacy, dosage, route, duration or interchangeability.

Quality and batch documentation

Quality information is batch- and presentation-specific. Use only the report linked to the exact size and lot. A report listed for another size, lot or similarly named material must not be treated as evidence for this product.

Chromatographic area purity, identity, net peptide or analyte content, water or counter-ion content, sterility, endotoxin and elemental impurities are different measurements. One result does not establish the others. Only tests supported by a visible, matching report should be regarded as available.

Laboratory handling and storage

Store and handle only under the conditions stated on the product label, batch CoA and SDS. Keep the container secured, correctly identified and protected from contamination. Do not infer storage, solvent compatibility or stability from a related compound.

This page intentionally provides no reconstitution, administration or dosing instructions. Laboratory preparation, analytical method selection, risk assessment, personal protective equipment and waste disposal must be defined by the qualified institution and the applicable SDS.

Regulatory and legal status

This catalogue material is not offered as a medicine, medical device, in-vitro diagnostic, food, dietary supplement, cosmetic or veterinary product. It is not intended to diagnose, treat, cure, mitigate or prevent any disease or condition.

A research designation does not override medicinal-product, controlled-substance, chemical, customs or other substance-specific rules. Availability may be restricted by jurisdiction and by the purchaser's verified professional or institutional status.

Sources and references

References document identity and research context only. They do not constitute instructions for use or evidence that this catalogue batch is suitable for any human or veterinary purpose.

  1. [1] UniProt P05019 — human IGF1 precursor and Ec-domain sequence context
  2. [2] Mechanisms of Ageing and Development — preclinical study of an MGF-related peptide construct
  3. [3] American Journal of Physiology-Endocrinology and Metabolism — non-confirmatory MGF-related study
  4. [4] Growth Hormone & IGF Research — analytical ambiguity of MGF-related molecular species

Frequently Asked Questions

What is this material intended for?

Controlled laboratory research by qualified professionals, including substantiated analytical, biochemical or non-clinical workflows. It is not intended for personal use.

Is the amount shown on the vial a dosage?

No. It is a nominal catalogue presentation used to identify the product variant. It is not a dose, concentration, administration schedule or preparation instruction.

Do the CAS number and PubChem CID apply to every batch form?

Only when the exact sequence or structure, termini, conjugation, salt or counter-ion and hydration state match. The batch CoA and SDS govern; a related-compound identifier must not be substituted.

What does an analytical purity result mean?

It is method- and report-specific. For example, an HPLC area percentage is not automatically the same as identity, net content, sterility, endotoxin status or absence of elemental impurities.

How should the material be stored and handled?

Follow the exact label, batch CoA and SDS, together with the institution's risk assessment. This page does not provide reconstitution or administration guidance.

May this material be used in humans or animals?

No. Human and veterinary use, including ingestion, injection, topical application, diagnosis, treatment, prevention and cosmetic use, is expressly excluded.

RESEARCH USE ONLY. NOT FOR HUMAN OR VETERINARY USE. THE PRODUCT NAME, VIAL AMOUNT AND LITERATURE REFERENCES MUST NOT BE INTERPRETED AS A DOSAGE, ADMINISTRATION INSTRUCTION OR MEDICAL CLAIM.

LABORATORY RESEARCH MATERIAL — FOR QUALIFIED PROFESSIONAL USE ONLY

For analytical, biochemical or non-clinical laboratory research only. Not for human or veterinary use. Not for ingestion, injection, topical application, inhalation, diagnostic, therapeutic, prophylactic or cosmetic use.

Research-use restrictions

Mandatory conditions:

  • Restricted to qualified professionals acting for verified laboratories, universities, companies or other research institutions.
  • The product name and nominal catalogue presentation are identifiers; they are not a dose, concentration, preparation protocol, ingestion instruction or administration instruction.
  • Before laboratory work, verify the exact material identity, sequence or structure, physical form, fill, salt or counter-ion, lot number and matching CoA and SDS.
  • Storage, handling, PPE, exposure response and disposal must follow the exact label, batch documentation, SDS and an institution-approved risk assessment.
  • The purchaser is responsible for institutional authorization and for jurisdiction-specific rules governing procurement, import, export, possession, storage and disposal.
  • Keep secured, correctly identified and inaccessible to children and all unauthorized persons.